![]() |
市場調查報告書
商品編碼
2149705
寵物健康與保健市場預測至2034年-按產品類型、服務類型、寵物品種、通路、最終用戶和地區分類的全球分析Pet Health and Wellness Market Forecasts to 2034 - Global Analysis By Product Type, Service Type, Pet Type, Distribution Channel, End User, and By Geography |
||||||
根據 Stratistics MRC 的數據,2026 年全球寵物健康和保健市場價值將達到 2,719 億美元,預計在預測期內將以 9.3% 的複合年成長率成長,到 2034 年達到 5,538 億美元。
寵物健康與保健是指旨在維護和改善伴侶動物身心健康的產品和服務。市場涵蓋的產品類型動物用藥品、營養補充品、診斷產品、口腔護理產品、皮膚和毛髮護理產品、關節和運動功能支援產品、消化器官系統健康產品以及行為和心理健康產品。服務類型包括獸醫診療、預防性獸醫服務、診斷服務、遠端醫療和數位獸醫服務、寵物復健和物理治療。寵物日益「人性化」、人們對寵物健康的日益關注以及獸醫服務的擴展是推動市場成長的主要因素。
人們對寵物健康和預防醫學的認知不斷提高
寵物飼主對預防保健和早期發現健康問題重要性的認知不斷提高,是推動寵物健康市場發展的主要動力。寵物飼主越來越重視定期帶寵物進行獸醫檢查、接種疫苗和接受預防性治療。同時,人們也越來越意識到營養在寵物健康中扮演的角色。早期發現和治療健康問題可以改善治療效果並降低長期成本。隨著寵物飼主將寵物健康放在首位,對相關產品和服務的需求不斷成長,從而支撐著市場的永續發展。
高昂的獸醫醫療費用和有限的保險覆蓋範圍
動物用藥品、診斷和先進治療的高昂費用,以及寵物保險覆蓋範圍的有限性,是限制市場發展的主要因素。先進的獸醫護理費用昂貴。在許多地區,寵物保險的普及率仍然很低。對費用的擔憂可能導致飼主推遲或放棄治療。這些費用障礙可能會限制市場成長,尤其是在先進醫療領域。
拓展遠端醫療和數位獸醫服務
遠距遠端醫療和數位化獸醫服務的日益普及為寵物健康市場帶來了巨大的機會。遠距醫療提高了寵物獲得獸醫專業知識的便利性。數位化監測工具能夠持續追蹤寵物的健康狀況。線上藥局擴大了藥品的取得管道。隨著數位化醫療的日益普及,這些服務的市場佔有率正在擴大。
與替代療法和家庭療法的競爭
來自替代療法和家庭療法的競爭對寵物健康市場構成重大威脅。有些寵物飼主可能更傾向於天然療法或自製療法。替代療法可以與傳統獸醫學競爭。價格敏感性也可能促使人們選擇DIY療法。這種競爭可能會限制專業產品和服務的市場成長。
新冠疫情加速了寵物健康市場的發展,因為寵物飼主更加重視自身健康,並花更多時間陪伴寵物。預防性醫療和保健產品的需求增加,遠端醫療服務顯著擴展,寵物保健產品的電商銷售額也隨之成長。即使在疫情結束後,人們對健康的持續關注也持續支撐著市場成長。
在預測期內,獸藥領域預計將佔據最大的市場佔有率。
預計在預測期內,獸用藥品領域將佔據最大的市場佔有率,這主要得益於藥品在伴侶動物疾病治療和預防中發揮的關鍵作用。獸用藥品包括抗生素、驅蟲藥、抗發炎藥和其他藥品。該領域正受益於持續的創新和治療方案的拓展。隨著寵物飼主對更先進護理的需求不斷成長,藥品在產品類型細分市場中保持最大的佔有率。
預計在預測期內,遠端保健和數位獸醫服務領域將呈現最高的複合年成長率。
在預測期內,受遠距醫療普及率不斷提高、智慧型手機滲透率持續上升以及消費者對便利獸醫服務需求的推動,遠距醫療和數位獸醫服務領域預計將呈現最高的成長率。遠距醫療能夠實現遠距會診和監測。該領域正受益於技術進步和消費者偏好的轉變。隨著數位醫療的普及加速,遠距醫療在各類服務領域中實現了最快的成長。
在預測期內,北美預計將佔據最大的市場佔有率,這主要得益於其較高的寵物擁有率、大量的寵物健康支出以及先進的獸醫基礎設施。美國透過對寵物健康的大量投資,正推動著該地區的成長。人們對預防性護理的高度重視也促進了市場需求。完善的獸醫網路為市場准入提供了保障。高額的支出和先進的醫療水準確保了北美在市場上的主導地位。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於中國、印度、日本和東南亞地區寵物擁有量的成長、可支配收入的增加以及人們對寵物健康意識的提高。該地區寵物數量的快速成長正在催生巨大的市場需求。不斷完善的獸醫基礎設施也為市場成長提供了支持。隨著人們對寵物健康意識的提高,亞太地區正經歷著全球寵物健康和保健市場最快的成長。
According to Stratistics MRC, the Global Pet Health and Wellness Market is accounted for $271.9 billion in 2026 and is expected to reach $553.8 billion by 2034 growing at a CAGR of 9.3% during the forecast period. Pet health and wellness encompasses products and services designed to maintain and improve the physical and mental health of companion animals. The market encompasses product types including veterinary pharmaceuticals, nutritional supplements, diagnostic products, dental care products, skin and coat care products, joint and mobility products, digestive health products, and behavioral and mental wellness products. Service types include veterinary care, preventive veterinary services, diagnostic services, telehealth and digital veterinary services, and pet rehabilitation and physiotherapy. Growing pet humanization, increasing awareness of pet health, and expanding veterinary services are key drivers of market expansion.
Growing awareness of pet health and preventive care
The increasing awareness among pet owners of the importance of preventive care and early detection of health issues is a primary driver for the pet health and wellness market. Pet owners are increasingly seeking regular veterinary check-ups, vaccinations, and preventive treatments. Awareness of nutrition's role in pet health is growing. Early detection and treatment of health conditions improves outcomes and reduces long-term costs. As pet owners prioritize health and wellness, demand for products and services expands, supporting sustained market growth.
High costs of veterinary care and limited insurance coverage
The significant costs associated with veterinary pharmaceuticals, diagnostics, and advanced treatments and limited pet insurance coverage represent a major restraint for the market. Advanced veterinary treatments can be expensive. Pet insurance penetration remains low in many regions. Cost concerns may lead pet owners to delay or forgo treatments. These cost barriers may constrain market growth, particularly for advanced care.
Expansion of telehealth and digital veterinary services
The growing adoption of telehealth and digital veterinary services presents significant opportunities for pet health and wellness market expansion. Remote consultations improve access to veterinary expertise. Digital monitoring tools enable continuous health tracking. Online pharmacies expand access to medications. As digital health adoption grows, these services capture growing market share.
Competition from alternative and home remedies
Competition from alternative therapies and home remedies poses significant threats to the pet health and wellness market. Some pet owners may prefer natural or homemade remedies. Alternative treatments may compete with conventional veterinary care. Price sensitivity may drive DIY approaches. This competition may limit market growth for professional products and services.
The COVID-19 pandemic accelerated pet health and wellness market growth as pet owners prioritized health and spent more time with their animals. Demand for preventive care and health products increased. Telehealth services expanded significantly. E-commerce sales of pet health products grew. Post-pandemic, continued health focus has supported market growth.
The Veterinary Pharmaceuticals segment is expected to be the largest during the forecast period
The Veterinary Pharmaceuticals segment is expected to account for the largest market share during the forecast period, driven by the essential role of medications in treating and preventing disease in companion animals. Veterinary pharmaceuticals include antibiotics, parasiticides, anti-inflammatories, and other medications. The segment benefits from continuous innovation and expanding treatment options. As pet owners seek advanced care, pharmaceuticals maintain the largest product type segment share.
The Telehealth and Digital Veterinary Services segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the Telehealth and Digital Veterinary Services segment is predicted to witness the highest growth rate, fueled by growing adoption of remote consultations, increasing smartphone penetration, and demand for convenient access to veterinary care. Telehealth enables remote consultations and monitoring. The segment benefits from technology advancements and changing consumer preferences. As digital health adoption accelerates, telehealth delivers the fastest service type segment growth.
During the forecast period, the North America region is expected to hold the largest market share, supported by high pet ownership, strong spending on pet health, and advanced veterinary infrastructure. The United States leads regional growth with substantial investment in pet health. High awareness of preventive care drives demand. Well-established veterinary networks support market accessibility. With high spending and advanced care, North America maintains its dominant market position.
Over the forecast period, the Asia-Pacific region is anticipated to exhibit the highest CAGR, driven by rising pet ownership, increasing disposable incomes, and growing awareness of pet health across China, India, Japan, and Southeast Asia. The region's rapidly growing pet population creates substantial demand. Increasing veterinary infrastructure supports market expansion. As pet health awareness grows, Asia Pacific delivers the fastest pet health and wellness market growth globally.
Key players in the market
Some of the key players in Pet Health and Wellness Market include Zoetis Inc., Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Merck & Co., Inc., Ceva Sante Animale, Virbac S.A., Vetoquinol S.A., Dechra Pharmaceuticals PLC, Mars, Incorporated, Nestle Purina PetCare, Hill's Pet Nutrition, Inc., Nutramax Laboratories, Inc., Zesty Paws, PetIQ, LLC, and Covetrus, Inc.
In September 2026, Boehringer Ingelheim Animal Health expanded veterinary preventative care and infectious disease monitoring programs across Europe.
In June 2026, Merck Animal Health entered into a definitive agreement to acquire TARGAN, integrating automated vision-guidance and biological delivery technologies into its portfolio.
In June 2026, Ceva Sante Animale acquired Spanish biotechnology firm Aquilon CyL S.L. to strengthen its animal microbiome research, gut health products, and preventative formulations.
In December 2025, Elanco Animal Health announced plans at its Investor Day to expand R&D and manufacturing investments in the U.S., highlighting an accelerated USDA review pathway for a novel companion animal immunotherapeutic.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW)
Regions are also represented in the same manner as above.